Last synced on 14 November 2025 at 11:06 pm

cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System

Page Type
Cleared 510(K)
510(k) Number
K223591
510(k) Type
Dual Track
Applicant
Roche Molecular Systems, Inc.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
7/27/2023
Days to Decision
238 days
Submission Type
Summary

cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® Liat® System

Page Type
Cleared 510(K)
510(k) Number
K223591
510(k) Type
Dual Track
Applicant
Roche Molecular Systems, Inc.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
7/27/2023
Days to Decision
238 days
Submission Type
Summary